tm logo
LUMAKRAS
REGISTERED

on 23 Aug 2023

Last Applicant/ Owned by

AMGEN INC.

One Amgen Center DriveThousand Oaks, CA 91320-1799

US

Serial Number

2076433 filed on 08th Jan 2021

Registration Number

TMA1194578 registered on 23rd Aug 2023

Registration expiry Date

23rd Aug 2033

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

LUMAKRAS

Trademark usage description

pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune disease Read More

Classification Information


Class [005]
Pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders


Classification kind code

11

Mark Details


Serial Number

2076433

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 190
on 23rd Aug 2023
Registration Pending
Submitted for opposition 55
on 23rd Aug 2023
Registered
Submitted for opposition 42
on 31st May 2023
Advertised
Submitted for opposition 26
on 02th May 2023
Approved
Submitted for opposition 27
on 02th May 2023
Approval Notice Sent
Submitted for opposition 22
on 26th Apr 2023
Search Recorded
Submitted for opposition 287
on 27th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 08th Jan 2021
Filed
Submitted for opposition 1
on 08th Jan 2021
Created
Submitted for opposition 31
on 08th Jan 2021
Formalized